| Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|
| Buys | +191K | 100% | $10.60 | +$2.02M |
| Sells | ||||
| Net | +191K | 100% | +$2.02M |
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 748K | $8.11M | $10.84 | Feb 18, 2025 | Indirect | ||
| Series A Convertible Preferred Stock | 0 | Sep 16, 2024 | By OrbiMed Private Investments VII, LP | Common Stock | |||
| Series B Convertible Preferred Stock | 0 | Sep 16, 2024 | By OrbiMed Private Investments VII, LP | Common Stock | |||
| Series C Convertible Preferred Stock | 0 | Sep 16, 2024 | By OrbiMed Genesis Master Fund, L.P. | Common Stock |
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|